Presented by:
James Finke, Ph.D.
Department of Immunology, Lerner Research Institute
The Cleveland Clinic Foundation

Dr. Finke's research efforts are directed toward defining the mechanisms by which the tumor microenvironment can negatively influence the development of T cell immunity to cancer. The major focus of his lab is on T cell suppression mechanisms in patients with renal cell carcinoma (RCC).

Light lunch served

Sponsored by the JCCC Genitourinary Oncology Program Area